ALLO
NASDAQ
$1.77
Allogene Therapeutics Inc (ALLO)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$465M
Free Cash Flow Yield
-23.55%
Price Chart
Valuation
Market Cap$465M
P/S7784.36
P/B2.29
Profitability
Gross Profit (TTM)-$132M
EBITDA-$178M
EPS-$0.76
Financial Health
Free Cash Flow Yield-23.55%
Growth & Risk
EPS 5Y CAGR-14.18%
FCF 5Y CAGR-9.83%
Sharpe Ratio0.80